Tag: FDA
Stocks Slide As Fears about DEA Dissent Boil Over
NEW YORK – An exchange-traded fund (ETF) that tracks some of the largest multistate operators (MSOs) fell nearly 17 percent during the first two...
The Frightening Reality of Synthetic Products
There is no shortage of unintended legislative consequences in the brief history of legal cannabis, but the 2018 Agricultural Improvement Act—popularly known as the...
New Vapor Cartridge Technology
STILLWATER, Minn. -- According to Timothy L. McCullough inventor and owner of Vapor Cartridge Technology LLC. "Vapor Cartridge Technologywas designed to revive the legal...
U.S. Health Officials Recommend Schedule III for Cannabis
WASHINGTON – The U.S. Department of Health and Human Services (HHS) has recommended reclassifying cannabis from Schedule I to a less restrictive Schedule III...
Brazilian Entrepreneur Bringing Revolutionary Hemp Products to U.S. Marketplace
BOCA RATON, Fla. --
Entourage Labs is thrilled to announce its impending debut into the U.S. marketplace, introducing a range of groundbreaking hemp-based products. Founded...
LightLab 3 Cannabis Analyzer Chosen by FDA to Enhance Consumer Safety and Regulation in...
NEW LONDON, N.H. --
Orange Photonics, a pioneer in revolutionizing HPLC technology, is proud to announce that the US Food and Drug Administration (FDA) has...
What the 2023 Farm Bill Could Mean for CBD and Other Cannabinoids
The 2018 Farm Bill revolutionized the hemp landscape, jump-starting an industry currently valued at more than $4 billion and expected to reach $16 billion...
Feds Signal Delta-8 Edibles Crackdown in New Warnings
SILVER SPRING, Md. – The federal government is cracking down on delta-8 edibles that resemble popular snack foods, according to letters two agencies sent...
Will Psychedelics Succeed Where Cannabis Has Struggled?
Plant-based medicines and therapeutics finally are gaining significant traction with the medical establishment. After decades of closed-mindedness, it’s about time.
However, the bright spotlight on...
Zelira secures US$8.6 million cornerstone funding for FDA clinical trials for HOPE-1(R) Cannabinoid Medicine...
Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a global leader in the development and commercialization of clinically validated cannabinoid-based medicines, is delighted to announce that it...